|
About:
|
First-in-Human, Single-Ascending Dose along with Food Influence Reports to evaluate the security, Tolerability, Pharmacokinetics and also Pharmacodynamics associated with Cetagliptin, any Dipeptidyl Peptidase-4 Inhibitor for the Diabetes type 2 Mellitus.
|
